Location History:
- Redwood City, CA (US) (2000)
- Quebec, CA (2000)
- Montreal, CA (1997 - 2002)
Company Filing History:
3 out of 517 
1 out of 53 Years Active: 1997-2002
Title: Innovations of Jennifer Grodberg
Introduction
Jennifer Grodberg is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of erythropoietin proteins. With a total of 4 patents, her work has advanced the understanding and application of these important proteins in medical science.
Latest Patents
Her latest patents include groundbreaking inventions such as "Recombinant human erythropoietin with altered biological activity." This patent focuses on DNA encoding modified, secretable erythropoietin proteins that differ in their ability to regulate the growth and differentiation of red blood cell progenitors compared to the wildtype recombinant erythropoietin. Another significant patent is related to "Erythropoietin DNA having modified 5' and 3' sequences." This invention provides nucleic acids encoding erythropoietin proteins with modifications in the noncoding sequences, allowing for the production of EPO proteins with altered activity.
Career Highlights
Throughout her career, Jennifer has worked with prestigious institutions such as Beth Israel Deaconess Medical Center, Inc. and New England Deaconess Hospital Corporation. Her experience in these organizations has contributed to her expertise in the field of biotechnology and patent development.
Collaborations
Jennifer has collaborated with various professionals in her field, including her coworker Arthur J. Sytkowski. These collaborations have further enhanced her research and innovation capabilities.
Conclusion
Jennifer Grodberg's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence advancements in medical science and the development of erythropoietin proteins.